OC Academy

Are exorbitant device costs limiting your patients’ access to life-saving structural heart therapies?

Swipe left to unpack the mechanism, the clinical implications, and the timeline for when this indigenous TAVR system will hit cath labs across the country.

The interpretation of EEG data has long been a diagnostic bottleneck in neurology.

Researchers at IIT Madras have unveiled MANAS-1, an indigenous foundational AI model that is doing for brainwaves what LLMs did for text. Swipe through to explore the mechanics and clinical impact of this “Made in India” breakthrough.

Ischemic strokes are a leading cause of mortality in India, often occurring silently until it’s too late. But what if AI could see what the human eye misses?

Researchers at IIT Palakkad and SCTIMST have just unveiled A-GMM-CNN—a groundbreaking AI framework that decodes the “vulnerability” of the plaque itself.

Swipe through to see how this AI-driven breakthrough is redefining the future of stroke prediction.

Is your Radiation Plan “Blind” to Daily Changes?
The adoption of AI-Driven Adaptive Radiotherapy (ART) and Proton Beam Therapy in India is redefining the “Therapeutic Ratio.” We are moving from static, margin-heavy treatments to dynamic, real-time adaptation.

Swipe to see how Indian centers are leading this precision revolution.

IndianDoctors CancerCareIndia ApolloHospitals YashodaHospitals MedEd PrecisionMedicine TechInMed

The MBBS syllabus got a massive upgrade.

In a landmark decision involving the ICMR, Clinical Research has now been integrated into the core medical curriculum across India. The goal is to transition from producing just clinicians to cultivating a generation of “Physician-Scientists.”

Swipe to see how this changes medical education forever.

ICMR MedEd FutureOfMedicine PublicHealthIndia EvidenceBasedMedicine DoctorLife

✨ Stepping into 2026 with hope, purpose, and new possibilities.
Here’s to fresh goals, meaningful growth, and a year full of learning and achievements. 🩺📚
Wishing you health, happiness, and success in everything you pursue.
Happy New Year from all of us at OC Academy! 🎉

Is Alzheimer’s truly irreversible?

For a century, the medical dogma has been clear: once neurons die, they are gone. Alzheimer’s management has been a game of slowing the inevitable. But breakthrough research from Case Western Reserve University is shattering this assumption.

By targeting the brain’s “energy crisis”—specifically NAD+ depletion—researchers have achieved something unprecedented: Full Cognitive Recovery in advanced Alzheimer’s models.

Swipe to see the molecule that could turn “decline” into “recovery.”➡️

MedicalBreakthrough P7C3 BrainHealth Neuroscience MedEd CaseWestern FutureOfMedicine

Is there a “right time” to treat cancer?

Study reveals a startling fact: Cancer metastasis isn’t a constant process. It follows a circadian rhythm, controlled by the HPA axis. Tumors appear to “wake up” and shed deadly cells primarily when the patient is asleep.

For Indian oncologists, this opens the door to Chronotherapy—optimizing treatment schedules to hit cancer exactly when it’s most vulnerable.

Swipe to understand the biology of time and how it could redefine chemotherapy protocols.

A watershed moment for Indian Neurology!

The S-RETRIEVE Trial, led by AIIMS New Delhi, has validated the Supernova Stent Retriever, an indigenous device that matches global gold standards in safety and efficacy.

Swipe to analyze the trial data and what this means for the future of stroke intervention in India. ➡️⚕️

StrokeCare MedicalInnovation SRETRIEVE Thrombectomy PublicHealthIndia MedEd ClinicalTrials

We’ve been staging cancer by its “body”, is it time to read its “mind”? 🧠

Enter OncoMark, a revolutionary AI framework developed by Indian scientists with over 96% accuracy.

Swipe to see how Indian AI is redefining the future of oncology. ➡️

The UK Health Security Agency (UKHSA) has confirmed the detection of a recombinant Mpox virus—a genetic fusion of Clade Ib and Clade IIb.

For Indian clinicians, this signals a need to move beyond simple PCR detection. Swipe for the breakdown of this new variant. ➡️

Is the “One-Drug” era over for Alzheimer’s?

The field is now undergoing a massive paradigm shift, moving from monotherapy to Multi-Target Combination Therapy.

Swipe to explore the multi-target approach redefining neurodegenerative care. ➡️